ZA200204455B - Use of dopamine-D3 receptor agonists for the therapy of salt-dependent hypertension. - Google Patents

Use of dopamine-D3 receptor agonists for the therapy of salt-dependent hypertension.

Info

Publication number
ZA200204455B
ZA200204455B ZA200204455A ZA200204455A ZA200204455B ZA 200204455 B ZA200204455 B ZA 200204455B ZA 200204455 A ZA200204455 A ZA 200204455A ZA 200204455 A ZA200204455 A ZA 200204455A ZA 200204455 B ZA200204455 B ZA 200204455B
Authority
ZA
South Africa
Prior art keywords
dopamine
therapy
salt
receptor agonists
dependent hypertension
Prior art date
Application number
ZA200204455A
Other languages
English (en)
Inventor
Bernd Muehlbauer
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of ZA200204455B publication Critical patent/ZA200204455B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200204455A 1999-11-04 2002-06-04 Use of dopamine-D3 receptor agonists for the therapy of salt-dependent hypertension. ZA200204455B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19953254 1999-11-04

Publications (1)

Publication Number Publication Date
ZA200204455B true ZA200204455B (en) 2003-09-04

Family

ID=7928007

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204455A ZA200204455B (en) 1999-11-04 2002-06-04 Use of dopamine-D3 receptor agonists for the therapy of salt-dependent hypertension.

Country Status (15)

Country Link
EP (1) EP1233815A1 (xx)
JP (1) JP2003513053A (xx)
KR (1) KR20020062300A (xx)
CN (1) CN1387450A (xx)
AU (1) AU1390801A (xx)
BR (1) BR0015310A (xx)
CA (1) CA2389643A1 (xx)
CZ (1) CZ20021521A3 (xx)
HU (1) HUP0203024A2 (xx)
IL (1) IL149266A0 (xx)
MX (1) MXPA02004103A (xx)
NO (1) NO20022142D0 (xx)
RU (1) RU2002114818A (xx)
WO (1) WO2001032263A1 (xx)
ZA (1) ZA200204455B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180599A1 (de) * 2000-08-16 2002-02-20 Siemens Building Technologies AG Sicherheitstechnische Einrichtung für eine Pumpe, die in einem Fluidgetriebe verwendet werden kann
JP2010184889A (ja) * 2009-02-12 2010-08-26 Nihon Univ 高血圧症予防治療薬
WO2011047350A2 (en) * 2009-10-16 2011-04-21 David Helton Emesis treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008219A (en) * 1995-03-27 1999-12-28 Smithkline Beech P.L.C. Bicyclic amine derivatives and their use as anti-psychotic agents
FR2742149B1 (fr) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
HUP0203024A2 (hu) 2003-02-28
IL149266A0 (en) 2002-11-10
KR20020062300A (ko) 2002-07-25
AU1390801A (en) 2001-05-14
NO20022142L (no) 2002-05-03
NO20022142D0 (no) 2002-05-03
CN1387450A (zh) 2002-12-25
EP1233815A1 (de) 2002-08-28
MXPA02004103A (es) 2003-08-20
WO2001032263A1 (de) 2001-05-10
RU2002114818A (ru) 2004-01-10
JP2003513053A (ja) 2003-04-08
BR0015310A (pt) 2002-07-09
CA2389643A1 (en) 2001-05-10
CZ20021521A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
HK1044952A1 (en) N-pyrazole A2A receptor agonists n- A2A.
ZA200200298B (en) C-Pyrazole A2A receptor agonists.
AU1293101A (en) Ep4 receptor selective agonists in the treatment of osteoporosis
MXPA03004623A (es) Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
ZA200108846B (en) Glucocorticoid receptor modulators.
AU5274499A (en) Therapeutic chemokine receptor antagonists
EP1224274A4 (en) TUMORNESCROSE FACTOR RELATED RECEPTOR, TR6
HK1047580A1 (en) Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes.
ZA200203450B (en) beta2-adrenergic receptor agonists.
ZA200201788B (en) Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for the treatment of pain.
HUP0202253A3 (en) Selective iglur5 receptor antagonists for the treatment of migraine
ZA200203909B (en) Bicyclic cannabinoid agonists for the cannabinoid receptor.
HK1045684A1 (en) Biphenyl derivatives as antagonists of the neurokinine-1 receptor.
GB0029100D0 (en) Compounds active at the glucocorticoid receptor
AU5861900A (en) Receptor agonists and antagonists
ZA200204455B (en) Use of dopamine-D3 receptor agonists for the therapy of salt-dependent hypertension.
AU6909400A (en) Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction
ZA200110046B (en) Therapeutic agents.
MXPA03004658A (es) Compuestos activos en el receptor glucocorticoide ii.
ZA200109120B (en) Use of Arylalkanoylpyridazines.
GB9927215D0 (en) Hormone receptor expression
MXPA01011286A (es) Derivados de ciclocarbamato como moduladores de receptor de progesterona.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
AU2002314319A1 (en) Use of adenosine a1 receptor agonists for the treatment of nociceptive pain
AU2512800A (en) Alpha1-adrenergic receptor antagonists